MedPath

Creating and Assessing a Voice Dataset for Automated Classification of Chronic Obstructive Pulmonary Disease

Completed
Conditions
Chronic Obstructive Pulmonary Disease
Interventions
Other: COPD
Registration Number
NCT05897944
Lead Sponsor
Blekinge Institute of Technology
Brief Summary

This work aims to evaluate whether voice recordings collected from patients diagnosed with COPD and healthy control groups can be used to detect the disease using machine learning techniques.

Detailed Description

Voice data and sociodemographic data on gender and age will be collected through the "VoiceDiganostic" application from the company Voice Diagnostic, which allows one to participate without location dependency. Participants with a diagnosis will be marked as the COPD group, and others will be marked as the healthy control group. Private information such as known comorbidities, personal security numbers, health parameters and communication information will be separately noticed in a participation table for each group.

The collected data will be transformed into mathematical vocal measures called voice features. A dataset consisting of voice features in conjunction with demographics and health data will be constructed for further usage as an input to ML techniques.

Descriptive statistical analysis will be held on attributes containing information on input data and gained outcomes from ML algorithms. The achieved results will be presented in the form of summary tables and graphs.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
72
Inclusion Criteria
  • being 18 years old and older.
Exclusion Criteria
  • being under 18 years old.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
HCCOPDParticipants without Chronic obstructive pulmonary disease diagnosis. Total 38 recruitment, 20 Female, 18 Male
COPDCOPDParticipants with clinically diagnosed Chronic obstructive pulmonary disease. Total 34 recruitment, 18 Female, 16 Male
Primary Outcome Measures
NameTimeMethod
AccuracyWeek 51

Binary detection performance of the ML algorithm

Input data importance scaleWeek 51

Features used as input data will be ranked from most important to less important one.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Blekinge Institute of Technology

πŸ‡ΈπŸ‡ͺ

Karlskrona, Blekinge, Sweden

Β© Copyright 2025. All Rights Reserved by MedPath